Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Ondek Announces Appointment of Chief Executive Officer

Published: Tuesday, March 19, 2013
Last Updated: Monday, March 18, 2013
Bookmark and Share
Dr Jenny Harry appointed as CEO of Australian Nobel prize winner’s Company.

Australian drug delivery system company Ondek Limited has announced the appointment of Dr Jenny Harry as Chief Executive Officer.

Ondek is developing innovative ways to deliver medical therapies using the discoveries of Australian Nobel Laureate Barry Marshall.

The Company is currently working to use the stomach bacteria that helped win Dr Marshall the top prize in medicine to fight childhood asthma and allergies.

Ondek Chairman Peter Hammond said, “Dr Harry will play a key role in the global commercialization of Ondek’s novel drug delivery technology. She has already had a significant and positive impact on the business and her experience and skills will be invaluable as we progress through the clinic and negotiate commercial alliances.”

Dr Harry is an experienced CEO of global biotechnology businesses. Before joining Ondek she served as CEO and Managing Director of Tyrian Diagnostics Limited (ASX: TDX) where she led the transformation of the Company from research and development to diagnostics and oversaw commercialization of its first diagnostic products.

She has experience in leading high performing teams, strategic planning and portfolio development, structuring and negotiating agreements with multi-nationals, raising capital for early stage biotechnology companies and investor relations.

Dr Harry has a PhD in developmental biology from Macquarie University, and is a graduate of the Harvard Business School General Manager Program and the Australian Institute of Company Directors. Dr Harry is based in Sydney at the offices of Exto Partners Pty Ltd.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Gene Therapy Going Global with Portable Device
Portable 'gene therapy in a box' could make future cancer and HIV cures affordable in developing countries.
Preventing "Friendly Fire" in the Pancreas
Researchers inhibit process that leads to the body attacking its own insulin-producing cells.
3D-Printed Heart-On-A-Chip with Integrated Sensors
Researchers have created the first 3D-printed organ-on-a-chip with integrated sensors, paving the way for more complex, customizable devices.
Wrapping up the Genome
Researchers successfully package complete yeast genome using purified components, yielding new insights into genome mechanisms.
Drug Target for Triple-Negative Breast Cancer Found
A team of researchers led by UC San Francisco scientists has identified a new drug target for triple-negative breast cancer.
Precision Medicine Guiding Cancer Patients’ Chemotherapy Decision
New study finds doctors use genetic test to measure breast cancer recurrence risk, make tailored treatment recommendations.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos